FDA.reportPublic FDA data

Tarka 4/240 (trandolapril / verapamil hydrochloride) 24 HR Extended Release Oral Tablet

RxCUI
897855
RxNorm name
Tarka 4/240 (trandolapril / verapamil hydrochloride) 24 HR Extended Release Oral Tablet
Display name
Tarka 4/240 (trandolapril / verapamil hydrochloride) 24 HR Extended Release Oral Tablet
Full name
Tarka 4/240 (trandolapril / verapamil hydrochloride) 24 HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3b4b1dd5-8a6f-4f0e-a2ea-506c60d6fce9Tarka 4 MG / 240 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR trandolapril 4 MG / verapamil hydrochloride 240 MG Extended Release Oral Tablet [Tarka] [SBD] · Tarka 4/240 (trandolapril / verapamil hydrochloride) 24 HR Extended Release Oral Tablet [SY] · Tarka 4/240 24 HR Extended Release Oral Tablet [SY]42TARKA® (trandolapril/verapamil hydrochloride ER tablets)20120213